Dispatch from Breaking Convention 2025: Insights from Europe’s Largest Psychedelic Research Conference (Part 1) Post published:April 29, 2025 Post category:Analysis/News
Pα+ Psychedelic Bulletin #194: Make-or-Break Moment Looms for Compass; RFK Jr. Discusses LSD Use; Europe’s Next Chapter in Psychedelic Therapy Begins in Barcelona Post published:April 25, 2025 Post category:Psychedelic Bulletin/Pα+
Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride Post published:April 18, 2025 Post category:Interviews/Pα+
High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center Post published:April 17, 2025 Post category:Analysis/News
The VA, Psychedelics, and the Future of Mental Health: A Conversation with Shereef Elnahal, Former VA Under Secretary for Health Post published:April 14, 2025 Post category:Interviews
Pα+ Psychedelic Bulletin #193: VA Secretary on Psychedelics; Preprint Challenges Replicability of Psilocybin’s Persistent Effects in Mice; Market Mayhem and Agency Shake-Ups Post published:April 11, 2025 Post category:Psychedelic Bulletin/Pα+
Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape Post published:April 9, 2025 Post category:Analysis/News/Pα+
BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act Post published:April 8, 2025 Post category:Analysis/News
March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms Post published:April 7, 2025 Post category:Analysis/News/Pα+